BMT-133218

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameBMT-133218
Drug Alias NameBMT-133218
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action +[1N/A
TargetsMetabotropic glutamate receptor 2
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A